Valerie Gruber, Ph.D., M.P.H.
Clinical Professor
University of California, San Francisco
Department of Psychiatry
San Francisco General Hospital
1001 Potrero Avenue, Ward 93/95
Box 0852
San Francisco, CA 94110
Tel: 415-206-3943
Fax: 415- 206-6875
email: Valerie.Gruber@sfdph.org
Selected Publications
Gruber, V.A. & McCance-Katz, E.F. (2010) Methadone, buprenorphine and street drug interactions with antiretroviral medications. Current HIV/AIDS Reports, 7(3), 152-160.
Haug, N.A., Shopshire, M., Tajima, B., Gruber, V., & Guydish, J. Adoption of evidence-based practices among substance abuse treatment providers. Journal of Drug Education, 38 (2), 181-192.
Gruber V.A. (2008). Stimulants and related drugs. In R. Albucher (Ed.) Psychiatry: Just the Facts. Burr Ridge, IL: McGraw-Hill.
Gruber V.A., Delucchi K.L., Kielstein A. & Batki S. L. (2008). A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug and Alcohol Dependence, 94, 199-206.
Gruber V.A., Sorensen J.L., & Haug N.A. (2007). Psychosocial predictors of adherence to highly active antiretroviral thearpy: Practical implications. Journal of HIV/AIDS and Social Services, 6 (1/2), 23-27.
Haug N.A., Sorensen J.L., Gruber V.A., & Lollo N. (2006). Medication adherence strategies for HIV-positive methadone clients: A treatment manual for implementing voucher incentives and medication coaching. Behavior Modification, 30 (6), 752-781.
Haug N.A., Sorensen, J.L., Gruber V.A. & Song, J.S. (2005). Relapse prevention for opioid dependence. In Marlatt, G.A., & Donovan, D. M. (Eds.), Relapse Prevention (2nd Ed.). New York: Guilford.
Batki S.L., Gruber V.A., Bradley J.M., Bradley M., Delucchi K.L. (2002). A controlled methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug and Alcohol Dependence, 66 (3) 283-293.